Repository logo
 
Publication

Belimumab in Systemic Lupus Erythematosus (SLE): Evidence-To-Date and Clinical Usefulness

dc.contributor.authorGuerreiro Castro, S
dc.contributor.authorIsenberg, D
dc.date.accessioned2017-04-19T15:12:26Z
dc.date.available2017-04-19T15:12:26Z
dc.date.issued2017-03
dc.description.abstractSystemic lupus erythematosus (SLE) is a complex autoimmune rheumatic disease with multiple presentations, whose management presents many challenges. Many disease modifying or immunosuppressive drugs have been used with limited success, especially in patients with more severe disease activity. Belimumab is the first drug to be approved specifically for the treatment of SLE in more than 50 years. By blocking the B-cell activating factor, it interferes in B-cell differentiation and survival. Here we consider the results of the clinical trials that led to its approval, as well as the post-hoc analyses, follow-up studies and the current trials.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationTher Adv Musculoskelet Dis. 2017 Mar;9(3):75-85pt_PT
dc.identifier.doi10.1177/1759720X17690474pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.17/2680
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherSAGE Publicationspt_PT
dc.subjectHCC MEDpt_PT
dc.subjectBelimumabpt_PT
dc.subjectBiologic Therapypt_PT
dc.subjectImmunosuppressive Agentspt_PT
dc.subjectSystemic Lupus Erythematosuspt_PT
dc.titleBelimumab in Systemic Lupus Erythematosus (SLE): Evidence-To-Date and Clinical Usefulnesspt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage85pt_PT
oaire.citation.issue3pt_PT
oaire.citation.startPage75pt_PT
oaire.citation.titleTherapeutic Advances in Musculoskeletal Diseasept_PT
oaire.citation.volume9pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Ther Adv Musculos Dis.pdf
Size:
1.03 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections